These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 6963850)

  • 1. Pulmonary infections in cystic fibrosis.
    Acta Paediatr Scand Suppl; 1982; 301():1-132. PubMed ID: 6963850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G; Gagliardini R; Rocchi AL; Palumbo P
    Minerva Pediatr; 1986 Jul; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infection and antibiotic therapy in respiratory manifestations of mucoviscidosis].
    Hennequet A
    Ann Pediatr (Paris); 1968 Mar; 15(3):223-30. PubMed ID: 5744295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Up-date on the antibiotic treatment of pulmonary infection in cystic fibrosis].
    Cobos Barroso N
    An Esp Pediatr; 1993 Oct; 39 Suppl 55():195-9. PubMed ID: 8291800
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection of the respiratory tract and lungs in cystic fibrosis.
    Williams RF
    Nurs Times; 1980 Mar; 76(12):517-20. PubMed ID: 6899128
    [No Abstract]   [Full Text] [Related]  

  • 6. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
    Valletta EA; Rigo A; Bonazzi L; Zanolla L; Mastella G
    Acta Univ Carol Med (Praha); 1990; 36(1-4):44-5. PubMed ID: 2130717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis: a case report.
    Mo-Suwan L; Chungpanich S
    J Med Assoc Thai; 1981 Dec; 64(12):630-5. PubMed ID: 6153031
    [No Abstract]   [Full Text] [Related]  

  • 8. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis.
    Gifford RR
    J S C Med Assoc; 1972 May; 68(5):204-7. PubMed ID: 4554120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-infectious therapy in cystic fibrosis].
    Otto HS
    Med Welt; 1974 Feb; 25(7):252-5. PubMed ID: 4816688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the child with cystic fibrosis.
    Byrne S; David TJ
    Br J Hosp Med; 1993 Oct 20-Nov 2; 50(8):445-51. PubMed ID: 8275282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Chest; 1988 Aug; 94(2 Suppl):97S-169S. PubMed ID: 3396440
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic progress--review XVIII. Cystic fibrosis.
    Kohler JA; Rolles CJ
    J Clin Hosp Pharm; 1986 Feb; 11(1):21-32. PubMed ID: 3514681
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute respiratory infections in patients with cystic fibrosis: role of viruses and mycoplasmas].
    Ojeda-Vargas M; Mateos M; Meseguer M; Baquero F
    Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):526. PubMed ID: 2095268
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystic fibrosis: intravenous treatment at home.
    Catchpole A
    Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cystic fibrosis: current therapy. Inhalation antibiotics].
    Mordasini C
    Schweiz Med Wochenschr Suppl; 2000; 122():43S-44S. PubMed ID: 12536472
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention and therapy of airway infections in patients with cystic fibrosis].
    Möller AV; Dankert-Roelse JE; Horrevorts AM; van Alphen L; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2350-3. PubMed ID: 7501073
    [No Abstract]   [Full Text] [Related]  

  • 18. First bacterial infection as an alternative clinical end point for regulatory approval of agents targeting the primary cystic fibrosis defect.
    VanDevanter DR
    J Pediatr; 2005 Sep; 147(3):332-4. PubMed ID: 16182671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic obstructive bronchopneumopathy with evolutive character in cystic fibrosis].
    Rigillo N; Masciale A; Manca A
    Arch Monaldi Mal Torace; 1989; 44(1-3):277-85. PubMed ID: 2520575
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P; Squinazi F; Tobelem R; Lemerle S; Lobut JB; Bernaudin F; Kohout G; Bouveret
    Pediatrie; 1984; 39(7):597-8. PubMed ID: 6598489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.